Positive Interim Clinical Data and Strategic Developments Justify Buy Rating for Neurogene

TipRanksNov 13 15:06 · Ratings

Positive Buy Rating for Taysha Gene Therapies Amidst Competitive Advantages Over Neurogene

TipRanksNov 13 15:06 · Ratings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 13 05:08

MediciNova MNOV Settlement; Neurogene NGNE Discontinuation

BioPharmCatalystNov 13 05:00

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings

BenzingaNov 13 03:31

Neurogene Stock Tanks After Adverse Event In Early-Stage Rett Syndrome Gene Therapy Trial

BenzingaNov 13 00:25